Close Menu
    Facebook X (Twitter) Instagram
    • Home
    • About Us
    • Digital Subscription
    • Advertisement
    • Contact Us
    X (Twitter) Instagram
    The Tennessee TribuneThe Tennessee Tribune
    Advertise With Us
    • Home
      • Featured
    • News
      • State
      • Local
      • National/International News
      • Global
      • Business
        • Commentary
        • Finance
        • Local Business
      • Investigative Stories
        • Affordable Housing
        • DCS Investigation
        • Gentrification
    • Editorial
      • National Politics
      • Local News
      • Local Editorial
      • Political Editorial
      • Editorial Cartoons
      • Cycle of Shame
    • Community
      • History
      • Tennessee
        • Chattanooga
        • Clarksville
        • Knoxville
        • Memphis
      • Public Notices
      • Women
        • Let’s Talk with Ms. June
    • Education
      • College
        • American Baptist College
        • Belmont University
        • Fisk
        • HBCU
        • Meharry
        • MTSU
        • University of Tennessee
        • TSU
        • Vanderbilt
      • Elementary
      • High School
    • Lifestyle
      • Art
      • Auto
      • Tribune Travel
      • Entertainment
        • 5 Questions With
        • Books
        • Events
        • Film Review
        • Local Entertainment
      • Family
      • Food
        • Drinks
      • Health & Wellness
      • Home & Garden
      • Featured Books
    • Religion
      • National Religion
      • Local Religion
      • Obituaries
        • National Obituaries
        • Local Obituaries
      • Faith Commentary
    • Sports
      • MLB
        • Sounds
      • NBA
      • NCAA
      • NFL
        • Predators
        • Titans
      • NHL
      • Other Sports
      • Golf
      • Professional Sports
      • Sports Commentary
      • Metro Sports
    • Media
      • Video
      • Photo Galleries
      • Take 10
      • Trending With The Tribune
    • Classified
    • Obituaries
      • Local Obituaries
      • National Obituaries
    The Tennessee TribuneThe Tennessee Tribune
    National/International News

    Every Batch Of India’s Covaxin Subject To Over 200 Quality Checks: Drugmaker

    zenger.newsBy zenger.newsAugust 6, 2021No Comments3 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit Email
    Share
    Facebook Twitter LinkedIn Pinterest Email
    Advertisement

    HYDERABAD, India — The manufacturer of India’s only indigenously-made vaccine in use has said every batch of doses produced has been subject to over 200 quality checks and approved by regulatory authorities amid reports of delayed production due to rejection based on unsatisfactory test results.

    “Every batch of Covaxin is subjected to more than 200 quality control tests at our facilities, followed by submission samples to Central Drugs Laboratory Government of India, only based on approval/release by Central Drugs Laboratory, are batches released commercially,” Bharat Biotech said.

    The statement came after reports that test batches of Covaxin from the Bengaluru plant were unsatisfactory and rejected, leading to delayed production.

    N.K. Arora, the chairperson of the Working Group of the National Technical Advisory Group on Immunisation, had previously said that the test batches of that plant were not satisfactory and got rejected, which led to a delay in ramping up production, “but now the batches have been approved by the competent authority and will be available for public consumption.”

    “All batches of Covaxin are manufactured and released only from our manufacturing facilities at Genome Valley Hyderabad, which are fully audited and approved by regulatory authorities,” said Bharat Biotech.

    “Hence we wish to put to rest any concerns on the quality of Covaxin.”

    Giving details of its manufacturing and quality checks, Bharat Biotech said it maintains a strict policy on safety and quality.

    “Bharat Biotech has not sought Indemnity from the Government of India for any adverse events from Covaxin,” said Bharat Biotech.

    Bharat Biotech informed that manufacturing of Covaxin commenced at Malur in Karnataka, and Ankleshwar in Gujarat, before which engineering batches were also executed to study equipment functionality.

    Products manufactured from these facilities will be available for supplies during September. This is based on the company’s 120-day timeline for manufacturing, testing, release, regulatory approvals, and distribution.

    The drugmaker said it is the only company to develop a vaccine indigenously in India and manufacture it on a large scale. It claimed that only Covaxin was the only jab to have demonstrated efficacy against the delta variant in phase III trials.

    Fake news and false and misleading narratives resulted in unintended consequences of creating panic in the country’s population, resulting in vaccine hesitancy.

    Meanwhile, Covaxin, on Aug. 5, received a certificate of Good Manufacturing Practice compliance from the Hungarian authorities.

    The approval was received from the National Institute of Pharmacy and Nutrition Hungary certifying the Goods Manufacturing Practices (GMP) for the manufacture of Covaxin.

    Bharat Biotech also intends to submit documentation for Emergency Use Authorization in several additional countries worldwide.

    “The recognition complements our commitment to driving world-class innovation and being a frontrunner in the research and development of vaccines,” said Bharat Biotech in the statement.

    Bharat Biotech’s Covid-19 vaccine Covaxin has shown less reduction in ‘neutralizing activity’ while comparing with Delta and Delta AY.1 (Delta plus) variants in those who are fully vaccinated with the vaccine, according to a study by the Indian Council of Medical Research-National Institute of Virology (NIV).

    This means that people vaccinated with Covaxin will be protected against the current variants Delta, Delta AY.1, and B.1.617.3.

    (With inputs from ANI)

    Edited by Saptak Datta and Krishna Kakani



    The post Every Batch Of India’s Covaxin Subject To Over 200 Quality Checks: Drugmaker appeared first on Zenger News.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    zenger.news
    • Website

    Related Posts

    FAA Releases Nationwide Ground Stop Questions and Answers

    November 18, 2026

    Carolyn Hugley Could Become Georgia’s First Black Woman House Speaker

    November 17, 2026

    It’s as if He Doesn’t Exist’: In Mississippi, People Jailed Months Without Formal Charges

    November 17, 2026

    Keisha Lance Bottoms to Govern State Where Her Great-Great-Grandfather Was Enslaved

    November 16, 2026

    TSU Alumnus Senior U.S. District Judge Curtis L. Collier Receives Nation’s Highest Honor at Supreme Court

    November 10, 2026

    HISTORY MADE: Keisha Lance Bottoms Becomes First Black Woman Elected Governor in American History

    November 10, 2026

    Comments are closed.

    Business

    Lyft and Waymo Prepare for Major Nashville Expansion

    November 18, 2026

    Nashville Hosts Historic Ghana-Tennessee Business Roundtable as Part of Four-Day Trade Mission

    November 17, 2026

    Sports Illustrated Resorts Opens in Nashville

    November 17, 2026
    1 2 3 … 413 Next
    Education
    Education

    Vanderbilt University Investigates Cybersecurity Attack, Ransomware Group Claims Data Breach

    By Tn TribuneNovember 18, 2026

    NASHVILLE, TN — Vanderbilt University is investigating a cybersecurity attack after a ransomware group claimed…

    LG Opens ‘Life’s Good Lounge’ at Vanderbilt University

    November 17, 2026

    Meharry Expands Women’s Health Services to Two Nashville Locations

    November 16, 2026

    WNBA Star A’ja Wilson Surprises Tennessee State Women’s Basketball Team With Custom Nike A’Two Sneakers

    November 16, 2026
    The Tennessee Tribune
    X (Twitter) Instagram
    • About Us
    • Digital Subscription
    • Store
    • Advertise With Us
    • Contact
    © 2026 The Tennessee Tribune - Site Designed by No Regret Media.

    Type above and press Enter to search. Press Esc to cancel.